Novel immunological approach to asses donor reactivity of transplant recipients using a humanized mouse model.

[1]  Sabine Tischer-Zimmermann,et al.  Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads , 2019, International journal of molecular sciences.

[2]  S. Sidhu,et al.  Humanized Mice for the Study of Immuno-Oncology. , 2018, Trends in immunology.

[3]  S. Fujiwara,et al.  Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  M. Zaitsu,et al.  Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses. , 2017, JCI insight.

[5]  Mamoru Ito,et al.  A Novel Xenogeneic Graft‐Versus‐Host Disease Model for Investigating the Pathological Role of Human CD4+ or CD8+ T Cells Using Immunodeficient NOG Mice , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  Jang-Gi Choi,et al.  Combination of IL-10 and IL-2 induces oligoclonal human CD4 T cell expansion during xenogeneic and allogeneic GVHD in humanized mice , 2017, Heliyon.

[7]  D. Greiner,et al.  Humanized Mouse Models of Clinical Disease. , 2017, Annual review of pathology.

[8]  A. Haverich,et al.  In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  F. Emmrich,et al.  Attenuation of graft‐versus‐host‐disease in NOD scid IL‐2Rγ−/− (NSG) mice by ex vivo modulation of human CD4+ T cells , 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[10]  S. Todo,et al.  A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation , 2016, Hepatology.

[11]  D. Schoenfeld,et al.  Induced regulatory T cells in allograft tolerance via transient mixed chimerism. , 2016, JCI insight.

[12]  D. Greiner,et al.  Humanized Mouse Models for Transplant Immunology , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  Paul L. Martin,et al.  Infectious Complications After Liver Transplantation. , 2015, Gastroenterology & hepatology.

[14]  S. Newbigging,et al.  Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation , 2015, PloS one.

[15]  Jang-Gi Choi,et al.  IL-10 exacerbates xenogeneic GVHD by inducing massive human T cell expansion. , 2015, Clinical immunology.

[16]  Sang Il Kim.  Bacterial infection after liver transplantation. , 2014, World journal of gastroenterology.

[17]  R. Lechler,et al.  Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34+ Stem Cells-Reconstituted NOD-scid IL2rγnull Mice , 2014, PloS one.

[18]  K. Wood,et al.  Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model , 2013, Transplantation.

[19]  P. V. D. van de Kerkhof,et al.  Humanized Mouse Model of Skin Inflammation Is Characterized by Disturbed Keratinocyte Differentiation and Influx of IL-17A Producing T Cells , 2012, PloS one.

[20]  F. Nestle,et al.  Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype , 2012, PloS one.

[21]  H. Ohdan,et al.  Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients. , 2012, Transplantation proceedings.

[22]  J. Delrow,et al.  Rescued Tolerant CD8 T Cells Are Preprogrammed to Reestablish the Tolerant State , 2012, Science.

[23]  Kathryn J Wood,et al.  Mechanisms of rejection: current perspectives. , 2012, Transplantation.

[24]  P. Ye,et al.  Dynamic changes in Th1, Th17, and FoxP3+ T cells in patients with acute cellular rejection after cardiac transplantation , 2011, Clinical transplantation.

[25]  R. Goto,et al.  Ex Vivo–Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse Model , 2010, Transplantation.

[26]  M. Roth,et al.  Reconstitution of huPBL-NSG Mice with Donor-Matched Dendritic Cells Enables Antigen-Specific T-cell Activation , 2010, Journal of Neuroimmune Pharmacology.

[27]  T. Starzl,et al.  Themes of liver transplantation , 2010, Hepatology.

[28]  K. Wood,et al.  In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells , 2010, Nature Medicine.

[29]  Raymond Dunn,et al.  NOD-scid IL2r&ggr;null Mouse Model of Human Skin Transplantation and Allograft Rejection , 2010, Transplantation.

[30]  D. Greiner,et al.  Human peripheral blood leucocyte non‐obese diabetic‐severe combined immunodeficiency interleukin‐2 receptor gamma chain gene mouse model of xenogeneic graft‐versus‐host‐like disease and the role of host major histocompatibility complex , 2009, Clinical and experimental immunology.

[31]  Graham M Lord,et al.  Relative roles of Th1 and Th17 effector cells in allograft rejection , 2009, Current opinion in organ transplantation.

[32]  C. Mathieu,et al.  Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation , 2008, Clinical and experimental immunology.

[33]  K. Brown,et al.  Homeostatic Proliferation of Lymphocytes Results in Augmented Memory-Like Function and Accelerated Allograft Rejection1 , 2008, The Journal of Immunology.

[34]  R. Woodland,et al.  A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. , 2008, Clinical immunology.

[35]  A. Matas,et al.  Pretransplant Donor-Specific and Non-Specific Immune Parameters Associated With Early Acute Rejection , 2008, Transplantation.

[36]  J. Pober,et al.  Human Effector Memory CD4+ T Cells Directly Recognize Allogeneic Endothelial Cells In Vitro and In Vivo , 2007, The Journal of Immunology.

[37]  R. Lechler,et al.  Allorecognition and the alloresponse: clinical implications. , 2007, Tissue antigens.

[38]  Y. Matsuzaki,et al.  Spleen Plays an Important Role in Maintaining Tolerance After Removal of the Vascularized Heart Graft , 2007, Transplantation.

[39]  Dale L. Greiner,et al.  Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.

[40]  J. Janosky,et al.  Enhanced Donor‐Specific Alloreactivity Occurs Independently of Immunosuppression in Children with Early Liver Rejection , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  J. Mir,et al.  De Novo Internal Neoplasms after Liver Transplantation: Increased Risk and Aggressive Behavior in Recent Years? , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[42]  William R. Burns,et al.  Interferon‐γ plays a nonredundant role in mediating T‐cell‐ dependent outward vascular remodeling of allogeneic human coronary arteries , 2004 .

[43]  J. Markmann,et al.  Homeostatic proliferation is a barrier to transplantation tolerance , 2004, Nature Medicine.

[44]  C. Magee,et al.  The growing problem of chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.

[45]  B. Stockinger,et al.  Involvement of Avidity for Major Histocompatibility Complex in Homeostasis of Naive and Memory T Cells , 2003, The Journal of experimental medicine.

[46]  H. Gudmundsdottir,et al.  A Closer Look at Homeostatic Proliferation of CD4+ T Cells: Costimulatory Requirements and Role in Memory Formation1 , 2001, The Journal of Immunology.

[47]  F. Powrie,et al.  Control of intestinal inflammation by regulatory T cells , 2001, Immunological reviews.

[48]  B. Woda,et al.  Regulation of Human Cell Engraftment and Development of EBV-Related Lymphoproliferative Disorders in Hu-PBL-scid Mice1 , 2000, The Journal of Immunology.

[49]  J. Pober,et al.  Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. , 1999, Transplantation.

[50]  S. Chung,et al.  Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. , 1998, Immunology letters.

[51]  A. del Palacio,et al.  Lipid abnormalities in stable liver transplant recipients – effects of cyclosporin, tacrolimus, and steroids , 1998, Transplant international : official journal of the European Society for Organ Transplantation.

[52]  H. Noreen,et al.  Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. , 1996, Human immunology.

[53]  A. Morris,et al.  Clinical significance of in vitro donor‐specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLR , 1994, Transplant international : official journal of the European Society for Organ Transplantation.

[54]  F. Ramsdell,et al.  Maintenance of in Vivo Tolerance by Persistence of Antigen , 1992, Science.

[55]  D. Dunn,et al.  CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS , 1979, The Lancet.